Sun Pharma Advanced Research Company Ltd vs Unjha Formulations Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Sun Pharma Advanced Research Company Ltd is ₹ 139.7 as of 04 May 10:18 . The P/E Ratio of Sun Pharma Advanced Research Company Ltd is 0 as of March 2023 .The P/E Ratio of Unjha Formulations Ltd is 0 as of March 2023 . The Market Cap of Sun Pharma Advanced Research Company Ltd is ₹ 5823 crore as of March 2023 .The Market Cap of Unjha Formulations Ltd is ₹ 0 crore as of March 2023 . The revenue of Sun Pharma Advanced Research Company Ltd for the Dec '25 is ₹ 8.45 crore as compare to the Sep '25 revenue of ₹ 7.87 crore. This represent the growth of 7.37% The revenue of Unjha Formulations Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sun Pharma Advanced Research Company Ltd for the Dec '25 is ₹ -69 crore as compare to the Sep '25 ebitda of ₹ -65.71 crore. This represent the growth of 5.01% The ebitda of Unjha Formulations Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.9 crore to ₹ -80.42 crore over 7 quarters. This represents a CAGR of -9.57% The net profit of Unjha Formulations Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Unjha Formulations Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
The Company works on innovation and new product development for global markets.
They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Limited was incorporated on March 1, 2006 as an innovative and development company.
It commenced operations on March 22, 2006.
As per Scheme of Arrangement, the entire business undertaking of the Innovative Research & Development including Novel Drug Delivery System (NDDS) Division of Sun Pharmaceuticals Industries' Research & Development Undertaking was transferred and vested into the Company effective from February 28, 2007.

About Unjha Formulations Ltd

Unjha Formulations Ltd was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat.
It was promoted by Shambhubhai A Patel.
The Company is a pioneer in Isabgol (Psyllium) Formulation.
The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc.
It is one of the largest manufacturers of isabgul products in India.

FAQs for the comparison of Sun Pharma Advanced Research Company Ltd and Unjha Formulations Ltd

Which company has a larger market capitalization, Sun Pharma Advanced Research Company Ltd or Unjha Formulations Ltd?

Market cap of Sun Pharma Advanced Research Company Ltd is 4,635 Cr while Market cap of Unjha Formulations Ltd is 9 Cr

What are the key factors driving the stock performance of Sun Pharma Advanced Research Company Ltd and Unjha Formulations Ltd?

The stock performance of Sun Pharma Advanced Research Company Ltd and Unjha Formulations Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sun Pharma Advanced Research Company Ltd and Unjha Formulations Ltd?

As of May 4, 2026, the Sun Pharma Advanced Research Company Ltd stock price is INR ₹142.85. On the other hand, Unjha Formulations Ltd stock price is INR ₹22.0.

How do dividend payouts of Sun Pharma Advanced Research Company Ltd and Unjha Formulations Ltd compare?

To compare the dividend payouts of Sun Pharma Advanced Research Company Ltd and Unjha Formulations Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.